As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon. Updates regarding government operating status and resumption of normal operations can be found at www.opm.gov . Despite the lapse in appropriations, IHS will continue to provide direct clinical health care services as well as referrals for contracted services that cannot be provided through IHS clinics. For more information on how IHS is impacted, visit: HHS Contingency Plan
Who May Prescribe
The Indian Health Service requires that prescribing practitioners have Drug Enforcement Administration licenses, unless they are prescribing under the auspices of institutions that have DEA licenses or they are members of the Public Health Service. However, even if you’re a prescribing practitioner working under an “umbrella” DEA license, it’s recommended that you get your own DEA license.
Revised Policy Regarding the Federal Government Doctor [PDF - 265 KB], FEDDOC Program, DEA Memorandum
Clarification regarding locum tenens registration [PDF - 37 KB], DEA letter
The DEA’s Practitioner’s Manual states that a prescription for a controlled substance may only be issued by a practitioner who is:
- Authorized to prescribe controlled substances by the jurisdiction in which the practitioner is licensed to practice,
- Registered with DEA or exempted from registration (that is, Public Health Service, Federal Bureau of Prisons, or military practitioners), or
- An agent or employee of a hospital or other institution acting in the normal course of business or employment under the registration of the hospital or other institution that is registered in lieu of the individual practitioner being registered (provided that additional requirements as set forth in the Code of Federal Regulations are met).
Indian Health Service. Office of Management Services. Indian Health Manual. Rockville, MD: US Department of Health and Human Services, 2009.
Drug Enforcement Administration. Office of Diversion Control. Practitioner’s Manual: An Informational Outline of the Controlled Substances Act (2006 Edition). By Joseph T. Rannazzisi and Mark W. Caverly. Washington, DC: US Department of Justice, 2006.
“Dispensing Controlled Substances for the Treatment of Pain; Policy Statement,” [PDF - 140 KB] Federal Register, Vol. 71, No. 172 (September 6, 2006), pp. 52,716-52,723.
Office of Diversion Control. Drug Enforcement Administration.